Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > 6 dollar target...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(121)
•••
Comment by BioTeckon Jul 06, 2022 2:52pm
189 Views
Post# 34805952

RE:RE:RE:RE:RE:6 dollar target...

RE:RE:RE:RE:RE:6 dollar target...Yeah bigtime institution buying coming in based on HC report.  Almost a whopping $200k worth. Must be some bigtime whales throwing that kinda cake around. Or maybe just a bakery worker.







Mercuryfilling1 wrote: I thought we were heading to $1.10 as well -  but I guess not. 

With a 10% jump on a down day, someone likes HC Wainright ...or perhaps the new corporate presentation got investors all twitterpated?



MustangSalley wrote:

HC Wainright ...are down right vultures . They finance you on one hand while their clients short you for free paper on the other hand. One of the most toxic frims out their. Even worse than Canacord. How much did they pay for this ? 

"Buh Bye" in the title suggests Wally wrote it.   

Sva comes up with a paid report and Vertex resumes their trial.  

$1.10 coming up .....





<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities